510(k) · Cleared
ClearedBriefCase
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Aidoc Medical, Ltd. · QAS Radiological Computer-Assisted Triage And Notification Software
Cleared on Jun 3, 2022 as substantially equivalent to K203508 (Aidoc Medical, Ltd., 2020) after a 29-day review. Its family tree reaches back 5 generations to 2018. 1 later device descends from it.
- Decided
- Jun 3, 2022
- Review
- 29 days
- Class
- Class II
- Product code
- QAS
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 5 generations to DEN170073 (2018). 8 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 5 generations backDEN170073 ContaCTViz.Al, Inc. · 2018
- 4 generations backK180647 BriefCaseAidoc Medical, Ltd. · 2018
- 3 generations backK190072 BriefCaseAidoc Medical, Ltd. · 2019
- 2 generations backK201020 BriefCaseAidoc Medical, Ltd. · 2020
- 1 generation backK203508 BriefCaseAidoc Medical, Ltd. · 2020
- This deviceK221314 BriefCaseAidoc Medical, Ltd. · 2022
- Descendant · cites it directly · 0 of its ownK231094 Annalise Enterprise CTB Triage-OHAnnalise-Ai Pty, Ltd. · 2023
Most influential descendants
Showing 1 of 1 · See all- K231094Annalise Enterprise CTB Triage-OHAnnalise-Ai Pty, Ltd. · 2023 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | DEN170073 | ContaCT | Viz.Al, Inc. | 2018 | — |
| −4 | K180647 | BriefCase | Aidoc Medical, Ltd. | 2018 | — |
| −3 | K190072 | BriefCase | Aidoc Medical, Ltd. | 2019 | — |
| −2 | K201020 | BriefCase | Aidoc Medical, Ltd. | 2020 | — |
| −1 | K203508 | BriefCase | Aidoc Medical, Ltd. | 2020 | — |
| 0 (this device) | K221314 | BriefCase | Aidoc Medical, Ltd. | 2022 | — |
| +1 | K231094 | Annalise Enterprise CTB Triage-OH | Annalise-Ai Pty, Ltd. | 2023 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2019 | 2 | 0 |
| 2020 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QAS device
- #1 K203508 BriefCasescore 25.5 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K203508 | BriefCaseSummary page 4…evice Regulatory Class: Class II Product Code: QAS (21 C.F.R. 892.2080) Primary Predicate Device: BriefCase LVO triage (K203508) Device Description BriefCase is a radiological computer-assisted triage and notification software device. The software system… | 2020 |
| † | K192383 | BriefCase | 2019 |
| † | K180647 | BriefCase | 2018 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K231094 | Annalise Enterprise CTB Triage-OH | 2023 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 8 months on median.
- None of the 8 ancestors has a recall.
- Of its descendants, K231094 (Annalise-Ai Pty, Ltd., 2023) has gone furthest, with 0 descendants of its own.
- 7 other devices also cite its predicate K203508.
How does its category compare?
All QAS devicesQAS Radiological Computer-Assisted Triage And Notification Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.
FDA decisions per year · QAS
15in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QAS
101in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QAS
No recall names QAS since 2007.
Adverse event reports per year · QAS
No MAUDE report names QAS since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 3 | — | 0 | 0 |
| 2019 | 5 | 111 | 0 | 0 |
| 2020 | 12 | 112 | 0 | 0 |
| 2021 | 5 | 86 | 0 | 0 |
| 2022 | 15 | 116 | 0 | 0 |
| 2023 | 11 | 98 | 0 | 0 |
| 2024 | 12 | 136 | 0 | 0 |
| 2025 | 15 | 101 | 0 | 0 |
| 2026 | 11 | 104 | 0 | — |
What is it indicated for?
BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of head CTA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of M1 Large Vessel Occlusion (M1-LVO) pathologies. BriefCase uses an artificial intelligence algorithm to analyze images and…
Read the full statement (178 words)
BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of head CTA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of M1 Large Vessel Occlusion (M1-LVO) pathologies.
BriefCase uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a standalone desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.
The results of BriefCase are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K221314 · printed Nov 6, 2026
Cite this page
510(k) Report. “K221314: BriefCase.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K221314
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026